Regimes for protecting pharmaceutical and biotechnological products via patents are slowly but steadily improving in many Latin American countries. Managing IP invited Alejandro Luna of Olivares & Cía, Guillermo Carey of HarneckerCarey Carey y Cía and in-house counsel Regina Kuchle to discuss some promising developments and continuing challenges
In its efforts to modernise the country’s IP system, Chile has made a series of legal amendments. Guillermo Carey and Francisco Carey of HarneckerCarey Carey y Cía provide a guide to the changes and look at the consequences for IP owners
Changes by the Mexican Institute of Industrial Property to the filing rules for divisional applications in Mexico have caused controversy and legal uncertainty, according to Octavio Espejo of Becerril Coca & Becerril
Laura Collada of Dumont Bergman Bider outlines the pros and cons of some recent changes to Mexican trade mark law
Gregory V Novak, James P Murphy and Suni Sukduang of Novak Druce + Quigg examine a troubling trend accompanying the recent meteoric rise in reexamination filings
María Milagros Nebreda of Hoet Peláez Castillo & Duque explains how the law related to a notorious brand, rather than a well-known one, has developed since the first case in 1990
Read this year's INTA Daily News - published daily by Managing IP direct from the 134th INTA Annual Meeting in Washington DC
May 2012
Do you want to be famous?
Famous, well-known, notorious, reputed: everyone wants enhanced protection for their trade marks. But should they, and what does it mean if it is? Emma Barraclough explains
Will the new post grant and inter partes review proceedings result in more litigators practising pro hac vice before the USPTO?